Coya Therapeutics, Inc. (COYA:NASDAQ) closed at $2.95 on November 20, 2026, down 1.01% on the day. The stock trades 55.4% below its 52-week high of $6.62 and 8.5% above its 52-week low of $2.72. Over the past year, it lost 51.2%. Coya Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, COYA closed higher on 113 days (45%). Its best day was May 14, 2026 (+15.86%) and its worst was January 15, 2026 (-13.15%). The stock moved 10% or more in a single session 6 times.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Find more stocks like COYA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.